Amoeba SA (ALMIB) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.187x

Based on the latest financial reports, Amoeba SA (ALMIB) has a cash flow conversion efficiency ratio of 0.187x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.67 Million ≈ $-3.12 Million USD) by net assets (€-14.27 Million ≈ $-16.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Amoeba SA - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Amoeba SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Amoeba SA (ALMIB) financial obligations for a breakdown of total debt and financial obligations.

Amoeba SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Amoeba SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ferronordic AB (publ)
ST:FNM
-0.029x
Northwest Copper Corp
V:NWST
-0.017x
Shanghai Yaohua Pilkington Glass Group Co Ltd B
SHG:900918
0.039x
Future Health Esg Corp
NASDAQ:FHLT
0.653x
VELA TECHNOL.PLC LS-0001
F:IBNN
N/A
Redtone International Bhd
KLSE:0032
-0.013x
Everest Industries Limited
NSE:EVERESTIND
-0.029x
Kukje Pharma Co Ltd
KO:002720
0.052x

Annual Cash Flow Conversion Efficiency for Amoeba SA (2012–2024)

The table below shows the annual cash flow conversion efficiency of Amoeba SA from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Amoeba SA worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-10.41 Million
≈ $-12.17 Million
€-4.22 Million
≈ $-4.93 Million
0.405x -75.44%
2023-12-31 €-3.94 Million
≈ $-4.61 Million
€-6.50 Million
≈ $-7.60 Million
1.649x +349.19%
2022-12-31 €8.16 Million
≈ $9.54 Million
€-5.40 Million
≈ $-6.32 Million
-0.662x +97.77%
2021-12-31 €198.68K
≈ $232.28K
€-5.90 Million
≈ $-6.90 Million
-29.704x -1727.93%
2020-12-31 €2.00 Million
≈ $2.34 Million
€-3.25 Million
≈ $-3.80 Million
-1.625x -89.00%
2019-12-31 €4.23 Million
≈ $4.94 Million
€-3.64 Million
≈ $-4.25 Million
-0.860x +12.73%
2018-12-31 €5.41K
≈ $6.33K
€-5.33K
≈ $-6.23K
-0.985x -142.87%
2017-12-31 €12.52K
≈ $14.64K
€-5.08K
≈ $-5.94K
-0.406x -32.43%
2016-12-31 €18.63K
≈ $21.78K
€-5.71K
≈ $-6.67K
-0.306x +22.04%
2015-12-31 €10.60K
≈ $12.39K
€-4.16K
≈ $-4.87K
-0.393x +7.81%
2014-12-31 €2.80 Million
≈ $3.27 Million
€-1.19 Million
≈ $-1.39 Million
-0.426x -136.98%
2013-12-31 €433.99K
≈ $507.38K
€500.21K
≈ $584.79K
1.153x +771.59%
2012-12-31 €947.20K
≈ $1.11 Million
€-162.56K
≈ $-190.04K
-0.172x --

About Amoeba SA

PA:ALMIB France Agricultural Inputs
Market Cap
$70.07 Million
€59.93 Million EUR
Market Cap Rank
#20866 Global
#328 in France
Share Price
€0.87
Change (1 day)
-2.25%
52-Week Range
€0.80 - €1.38
All Time High
€38.22
About

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more